| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.24 | 6e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |